Evaluation of the quality of life of patients with localizad prostate cancer: validation of the Spanish version of the EPIC;Evaluación de la calidad de vida de los pacientes con cáncer de próstata localizado: validación de la versión española del cuestionario EPIC

Medicina Clinica

Volumn 132, Issue 4, 2009, Pages 128-135

  Ferrer, Montse ^a,b,c   Garin, Olatz ^a,b   Pera, Joan ^d   Prats, Josep Maria ^e,f   Mendivil, Joan ^a,g   Alonso, Jordi ^a,b   De Paula, Belén ^h   Herruzo, Ismael ⁱ   Hervas, Asunción ^j   Macias, Víctor ^k   Mariño, Alfonso ^l   Ortiz, María José ^m   Pastor, Sergio ^e,f   Ponce De León, Javier ⁿ   Sancho, Gemma ^o  

^a HOSPITAL DEL MAR   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^e HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^f Service of Pediatrics   (Spain)

^g AGÈNCIA DE SALUT PÚBLICA DE BARCELONA   (Spain)

^h Instituto Oncologico de Guipuzcoa   (Spain)

ⁱ HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^j HOSPITAL RAMÓN Y CAJAL   (Spain)

^k HOSPITAL GENERAL DE CATALUNYA   (Spain)

^l Centro Oncologico de Galicia   (Spain)

^m HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

ⁿ FUNDACIÓ PUIGVERT   (Spain)

^o HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

more..

Author keywords

Brachytherapy; External radiotherapy; Prostate cancer; Prostatectomy; Quality of Life; Validity

Indexed keywords

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; QUESTIONNAIRE;

AGED; HUMANS; LANGUAGE; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 59749104926     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2008.01.001     Document Type: Article

References (30)

1. González J.R., Moreno V., Fernández E., Izquierdo A., Borras J., and Gispert R. Probabilidad de desarrollar y morir por cáncer en Cataluña en el período 1999-2001. Med Clin (Barc) 124 (2005) 411-414
2. Moroto-Robles J. ¿Ha pasado la época del antígeno prostático específico?. Med Clin (Barc) 126 (2006) 579-580
3. Litwin M.S., Hays R.D., Fink A., Ganz P.A., Leake B., Leach G.E., et al. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA 273 (1995) 129-135
4. Miller D.C., Sanda M.G., Dunn R.L., Montie J.E., Pimentel H., Sandler H.M., et al. Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy. J Clin Oncol 23 (2005) 2772-2780
5. Moul J.W., Anderson J., Penson D.F., Klotz L.H., Soloway M.S., and Schulman C.C. Early prostate cancer: prevention, treatment modalities, and quality of life issues. Eur Urol 44 (2003) 283-293
6. Borghede G., and Sullivan M. Measurement of quality of life in localized prostatic cancer patients treated with radiotherapy. Development of a prostate cancer-specific module supplementing the EORTC QLQ-C30. Qual Life Res 5 (1996) 212-222
7. Esper P., Mo F., Chodak G., Sinner M., Cella D., and Pienta K.J. Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument. Urology 50 (1997) 920-928
8. Giesler R.B., Miles B.J., Cowen M.E., and Kattan M.W. Assessing quality of life in men with clinically localized prostate cancer: development of a new instrument for use in multiple settings. Qual Life Res 9 (2000) 645-665
9. Befort C.A., Zelefsky M.J., Scardino P.T., Borrayo E., Giesler R.B., and Kattan M.W. A measure of health-related quality of life among patients with localized prostate cancer: results from ongoing scale development. Clin Prostate Cancer 4 (2005) 100-108
10. Wei J.T., Dunn R.L., Litwin M.S., Sandler H.M., and Sanda M.G. Development and validation of the Expanded Prostate Cancer Index Composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology 56 (2000) 899-905
11. Litwin M.S., Hays R.D., Fink A., Ganz P.A., Leake B., and Brook R.H. The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. Med Care 36 (1998) 1002-1012
12. Sanda M.G., Dunn R.L., Sandler H.M., McLaughlin P.W., Montie J.E., and Wei J.T. Comparison of health-related quality of life after brachytherapy, radical prostatectomy, or external beam radiation for localized prostate cancer. ASCO Proc 19 (2000) 327a
13. Wei J.T., Dunn R.L., Sandler H.M., McLaughlin P.W., Montie J.E., Litwin M.S., et al. Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. J Clin Oncol 20 (2002) 557-566
14. Hollenbeck B.K., Dunn R.L., Wei J.T., Montie J.E., and Sanda M.G. Determinants of long-term sexual health outcome after radical prostatectomy measured by a validated instrument. J Urol 169 (2003) 1453-1457
15. Hollenbeck B.K., Wei J.T., Sanda M.G., Dunn R.L., and Sandler H.M. Neoadjuvant hormonal therapy impairs sexual outcome among younger men who undergo external beam radiotherapy for localized prostate cancer. Urology 63 (2004) 946-950
16. Ferrer M., Alonso J., Prieto L., Plaza V., Monso E., Marrades R., et al. Validity and reliability of the St George's Respiratory Questionnaire after adaptation to a different language and culture: the Spanish example. Eur Respir J 9 (1996) 1160-1166
17. Ferrer M., Vilagut G., Monasterio C., Montserrat J.M., Mayos M., and Alonso J. Medida del impacto de los trastornos del sueño: las versiones españolas del cuestionario del impacto funcional del sueño y de la escala de somnolencia de Epworth. Med Clin (Barc) 113 (1999) 250-255
18. Scientific Advisory Committee of the Medical Outcomes Trust. Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res 11 (2002) 193-205
19. Ferrer M., Córdoba J., Garin O., Olive G., Flavia M., Vargas V., et al. Validity of the Spanish version of the Chronic Liver Disease Questionnaire (CLDQ) as a standard outcome for quality of life assessment. Liver Transp 12 (2006) 95-104
20. Kazis L.E., Anderson J.J., and Meenan R.F. Effect sizes for interpreting changes in health status. Med Care 27 (1989) S178-S189
21. Vilagut G., Ferrer M., Rajmil L., Rebollo P., Permanyer-Miralda G., Quintana J.M., et al. El cuestionario de salud SF-36 español: una década de experiencia y nuevos desarrollos. Gac Sanit 19 (2005) 135-150
22. Cella D., Hernández L., Bonomi A.E., Corona M., Vaquero M., Shiomoto G., et al. Spanish language translation and initial validation of the functional assessment of cancer therapy quality-of-life instrument. Med Care 36 (1998) 1407-1418
23. Batista Miranda J.E., Sevilla-Cecilia C., Torrubia R., Musquera M., Huguet-Pérez J., Ponce de Leon X., et al. Quality of life in prostate cancer and controls: psychometric validation of the FACTP-4 Spanish, and relation to urinary symptoms. Arch Esp Urol 56 (2003) 447-454
24. Ware J.E., Kosinski M., and Dewey J.E. How to score version 2 of the SF-36 Health Survey (standard & acute forms) (2000), Quality Metric Incorporated, Lincoln RI
25. Cronbach L.J. Coefficient alpha and the internal structure of tests. Psychometrika 16 (1951) 297-334
26. Nunnally J.C., and Bernstein I.H. Psychometric theory. 3rd ed (1994), McGraw-Hill, New York
27. Valderas J.M., Ferrer M., and Alonso J. Lista de comprobación: instrumentos de medida de calidad de vida relacionada con la salud y de otros resultados percibidos por los pacientes. Med Clin (Barc) 125 Supl 1 (2005) 58-62
28. Andresen E.M., Lollar D.J., and Meyers A.R. Disability outcomes research: why this supplement, on this topic, at this time?. Arch Phys Med Rehabil 81 (2000) S1-S4
29. Lee W.R., Hall M.C., McQuellon R.P., Case L.D., and McCullough D.L. A prospective quality-of-life study in men with clinically localized prostate carcinoma treated with radical prostatectomy, external beam radiotherapy, or interstitial brachytherapy. Int J Radiat Oncol Biol Phys 51 (2001) 614-623
30. Borchers H., Kirschner-Hermanns R., Brehmer B., Tietze L., Reineke T., Pinkawa M., et al. Permanent 125I-seed brachytherapy or radical prostatectomy: a prospective comparison considering oncological and quality of life results. BJU Int 94 (2004) 805-811